Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment

被引:23
|
作者
Karst, Sonja G. [1 ]
Lammer, Jan [1 ]
Mitsch, Christoph [1 ]
Schober, Manuela [1 ]
Mehta, Janhvi [1 ,2 ]
Scholda, Christoph [1 ]
Kundi, Michael [3 ]
Kriechbaum, Katharina [1 ]
Schmidt-Erfurth, Ursula [1 ]
机构
[1] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria
[2] Jaslok Hosp & Res Ctr, Mumbai, Maharashtra, India
[3] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria
关键词
Diabetic retinopathy; Diabetic macula edema; Ranibizumab; Triamcinolone; OCT; Fluorescein angiography; OPTICAL COHERENCE TOMOGRAPHY; FLUORESCEIN ANGIOGRAPHY; DEFERRED LASER; VISUAL-ACUITY; PATTERNS; OUTCOMES; PROMPT;
D O I
10.1007/s00417-017-3828-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Our purpose was to compare the impact in diabetic macula edema (DME) of two intravitreal drugs (0.5 mg ranibizumab vs. 8 mg triamcinolone) on changes in retinal morphology in spectral-domain optical coherence tomography (SD OCT) images, color fundus photography (CF) and fluorescein angiography (FA) images during a 1-year follow-up. Methods Post hoc analysis was conducted of morphologic characteristics in OCT, FA and CF images of eyes with a center involving DME that were included in a prospective double-masked randomized trial. Eligible patients were divided at random into two groups receiving either pro re nata treatment with 0.5 mg ranibizumab or 8 mg triamcinolone after a fixed loading dose. OCT and CF images were acquired at monthly visits and FA images every three months. Results Twenty-five eyes of 25 patients (ranibizumab: n = 10; triamcinolone: n = 15) were included in this study. Patients treated with ranibizumab showed better visual acuity results after 12 months than patients receiving triamcinolone (p = 0.015) although edema reduction was similar (p = 0.426) in both groups. The initial effect on macular edema shedding after a single ranibizumab injection could be amplified with the following two injections of the loading dose. After a single injection of triamcinolone the beneficial initial effect on the macula edema faded within 3 months. Subretinal fluid and INL cystoid spaces diminished early in the course of treatment while fluid accumulation in the ONL seemed to be more persistent in both treatment arms. In FA, the area of leakage diminished significantly in both treatment arms. After repeated injections the morphologic OCT and FA characteristics of the treatment arms converged. Conclusions Despite the higher dosage of triamcinolone, both therapies were safe and effective for treating diabetic macular edema. Fluid accumulation in the INL and subretinal space was more responsive to therapy than fluid accumulation in the ONL.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [31] DEMOGRAPHIC, PAYER, AND CLINICAL CHARACTERISTICS OF PATIENTS RECEIVING BEVACIZUMAB (BEV) AND RANIBIZUMAB (RAN) FOR TREATMENT OF DIABETIC RETINOPATHY (DR) AND DIABETIC MACULAR EDEMA (DME)
    Chung, J.
    Radtchenko, J.
    Nero, D.
    Nabhan, C.
    Kish, J.
    Feinberg, B.
    VALUE IN HEALTH, 2018, 21 : S243 - S243
  • [32] Baseline hemodynamics and retinal thickness of diabetic patients at risk for the development treatable diabetic macular edema (DME)
    Guan, K
    Hudson, C
    Lam, WC
    Mandelcorn, M
    Devenyi, RG
    Harvey, PT
    Rawji, M
    Wong, T
    Nrusimhadevara, R
    Flanagan, JG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U425 - U425
  • [33] Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
    Chiu, Chiung-Yi
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Chen, Fang-Ting
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Wang, Jia-Kang
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2021, 11 (03) : 251 - 258
  • [34] Characteristics of macular morphology and microcirculation in diabetic macular edema patients with serous retinal detachment
    Xu, Min
    Xu, Huirong
    Li, Xiao
    Chen, Fang
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [35] Characteristics of macular morphology and microcirculation in diabetic macular edema patients with serous retinal detachment
    Min Xu
    Huirong Xu
    Xiao Li
    Fang Chen
    BMC Ophthalmology, 22
  • [36] Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema
    Douvali, Maria
    Chatziralli, Irini P.
    Theodossiadis, Panagiotis G.
    Chatzistefanou, Klio I.
    Giannakaki, Emmanouella
    Rouvas, Alexandros A.
    OPHTHALMOLOGICA, 2014, 232 (03) : 136 - 143
  • [37] Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema
    Gundogdu, Kuebra Ozata
    Dogan, Emine
    celik, Erkan
    Alagoz, Guersoy
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (07)
  • [38] Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema
    Koc, Irem
    Kadayifcilar, Sibel
    Eldem, Bora
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 85 - 93
  • [39] Port Delivery System with Ranibizumab (PDS) in Diabetic Retinopathy (DR) with or without Diabetic Macular Edema (DME)
    Chang, Margaret
    Bobbala, Ashwini
    Malhotra, Varun
    Latkany, Paul
    DIABETES, 2021, 70
  • [40] THE TREATMENT OF DIABETIC MACULAR EDEMA WITH RANIBIZUMAB IN YOUNG PATIENTS WITH DIABETES TYPE 1
    Stefanickova, J.
    Krajcova, P.
    Javorska, L.
    Mruzkova, P.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 466 - 466